Novozymes disappoints in Q3 earnings on 'weak sales'
October 26, 2016 at 02:40 AM EDT
"It's mainly due to bioenergy in the U.S. and the situation keeps deteriorating as our customers are living through a very difficult time," says CEO.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|